Form 4: Vita Coco CMO Jane Prior Executes Pre-Planned Stock Option Exercise and Sale
Insider Trading Report
Vita Coco Company, Inc.'s Chief Marketing Officer, Jane Prior, completed a pre-arranged exercise of stock options and subsequent sale of common stock on July 1, 2025, as part of a Rule 10b5-1 trading plan.
Summary
- Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), engaged in a pre-planned transaction on July 1, 2025.
- Exercised 10,000 non-qualified stock options at an exercise price of $10.178 per share.
- Sold 10,000 shares of common stock at a weighted average price of $37.0701 per share.
- The sales were executed in multiple transactions at prices ranging from $37.00 to $37.24 per share.
- Following these transactions, Jane Prior beneficially owns 134,188 shares of common stock directly.
- Additionally, Jane Prior holds various non-qualified stock options with different exercise prices and vesting schedules, totaling 155,729 underlying shares.
Sentiment
Score: 5
Explanation: The document reports a routine, pre-planned insider transaction (exercise and sale of stock options) under a Rule 10b5-1 plan. This type of filing is standard disclosure and does not inherently indicate positive or negative sentiment regarding the company's performance or outlook.
Positives
- The exercise of stock options at $10.178 and subsequent sale at a weighted average price of $37.0701 indicates a significant personal gain for the Chief Marketing Officer from the appreciation of Vita Coco's stock.
- The transaction was conducted under a Rule 10b5-1 trading plan, demonstrating pre-planning and adherence to insider trading regulations.
Future Outlook
This document, an SEC Form 4, reports changes in beneficial ownership by an insider and does not contain forward-looking statements or guidance regarding the company's future outlook.
Management Comments
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.24, inclusive.
- The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Industry Context
This SEC Form 4 filing details an individual insider transaction and does not provide information related to broader industry trends or competitor analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Disclosure | The reported transactions were conducted under a Rule 10b5-1 trading plan, which is a pre-arranged plan designed to allow insiders to sell company stock without being accused of insider trading. | 2025-07-01 | Enhances transparency and provides an affirmative defense against insider trading allegations for the reporting person. |
Stakeholder Impact
- Shareholders: Provides transparency regarding insider stock transactions, which can be a factor in investment decisions, though a 10b5-1 plan typically mitigates concerns about reactive selling.
- Employees: No direct impact mentioned, but the exercise of options highlights the value of equity compensation.
Next Steps
- Future vesting of various non-qualified stock options on their respective anniversary dates, provided continuous service.
Key Dates
| Date | Description |
|---|---|
| 2022-11-27 | Start of four equal annual installments for vesting of stock options with an exercise price of $15. |
| 2024-03-10 | Start of four equal annual installments for vesting of stock options with an exercise price of $16.91. |
| 2025-03-04 | Start of four equal annual installments for vesting of stock options with an exercise price of $26.18. |
| 2025-07-01 | Date of stock option exercise and common stock sale transactions. |
| 2025-07-02 | Signature date of the reporting person's attorney-in-fact. |
| 2025-08-15 | Start of three equal annual installments for vesting of stock options with an exercise price of $15.36. |
| 2029-12-16 | Expiration date for fully vested non-qualified stock options with an exercise price of $10.178. |
| 2030-02-10 | Expiration date for fully vested non-qualified stock options with an exercise price of $10.178. |
| 2031-01-11 | Expiration date for fully vested non-qualified stock options with an exercise price of $10.178. |
| 2031-10-21 | Expiration date for non-qualified stock options with an exercise price of $15. |
| 2032-08-15 | Expiration date for non-qualified stock options with an exercise price of $15.36. |
| 2033-03-10 | Expiration date for non-qualified stock options with an exercise price of $16.91. |
| 2034-03-04 | Expiration date for non-qualified stock options with an exercise price of $26.18. |
| 2035-03-04 | Expiration date for non-qualified stock options with an exercise price of $33.36. |
Keywords
Vita Coco Company Inc., COCO, SEC Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Rule 10b5-1 Plan, Jane Prior, Chief Marketing Officer, Beneficial Ownership, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.